Company intelligence
Alzheimer's Disease International
The international federation of Alzheimer's and dementia associations around the world.
About Alzheimer's Disease International
Alzheimer's Disease International (ADI) is the international federation of Alzheimer associations around the world, in official relations with the World Health Organization. ADI's vision is an improved quality of life for people with dementia and their families throughout the world. Each of our members is a non-profit Alzheimer association supporting people with dementia and their families. ADI aims to make dementia a global health priority, to build and strengthen Alzheimer associations, and to raise awareness about dementia worldwide. Stronger Alzheimer associations are better able to meet the needs of people with dementia and their carers. Key activities • Raising global awareness through World Alzheimer's Month™ (September every year). • Providing Alzheimer associations with training in running a non-profit organization through our Alzheimer University programme. • Hosting an international conference where staff and volunteers from Alzheimer associations meet each other as well as medical and care professionals, researchers, people with dementia and their carers. • Disseminating reliable and accurate information through our website and publications. • Supporting the 10/66 Dementia Research Group's work on the prevalence and impact of dementia in developing countries. ADI is based in London and is registered as a non-profit organization in Illinois, USA.
Verified activity
Signals from Alzheimer's Disease International
7 published signals
People
Alzheimer's Disease International welcomed Valentina Combariza, Lucas Cose, Sadikun Nabi, Cinde Gaharu, Dany Ngoumen NGASSA, Mundih Noelar Njohjam MD, MSc, Ella Haines-Messenger and Tahira Kanwal to the Digital Intern Programme for World Alz Month in September 2026.
Reported by Alzheimer's Disease International
Presence & Recognition
Alzheimer's Disease International published the 2026 World Alzheimer Report focusing on demystifying the clinical trial landscape.
Reported by Alzheimer's Disease International
Research & Knowledge
Alzheimer's Disease International is entering a new era in dementia innovation with new diagnostic tools and emerging treatments in 192 trials.
Reported by Alzheimer's Disease International
Research & Knowledge
Alzheimer's Disease International will launch the latest World Alzheimer Report on 21 September, focusing on dementia clinical trials.
Reported by Alzheimer's Disease International
Presence & Recognition
Alzheimer's Disease International featured Scottish Brain Sciences at the National Galleries Scotland Modern One in Edinburgh to discuss Alzheimer's research and brain health.
Reported by Alzheimer's Disease International
Presence & Recognition
Alzheimer's Disease International is inviting people living with dementia to join the Global Dementia Expert Panel (GDEP) to share perspectives and help inform advocacy, research, and policy work.
Reported by Alzheimer's Disease International
Legal & Regulatory
Alzheimer's Disease International welcomed Alison Learning as the first global online education provider to achieve ADI Accreditation for Dementia Education.
Reported by Alzheimer's Disease International